Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 6595

A sealed prediction that did not hold.

no effect in discovery (spearman rho +0.12, p 0.761). This receipt's hash covers every field on it, plus the hash of receipt 6594, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 6595
    22 Oct 2026, 16:08 UTC

    CYP4A22

    dopamine neurons, braak

    predictionCYP4A22 in dopamine neurons tracks Braak Lewy-body stage

    registered9758c62de80614e9

    discovery+0.12 p=0.761 n=9

    replication-0.19 p=0.631 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho +0.12, p 0.761)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    13bc2c5fca4a9dc414c33c9a…
    follows 193fa6c547b6…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 6595: CYP4A22 in dopamine neurons, braak

power
full sample +0.02 (p 0.949, n 18), 95% CI -0.45 to +0.48. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: +0.02 (p 0.949, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.05 (p 0.840, n 18). could be the mix.
skeptic
leave-one-out range -0.10 to +0.14, sign flips 6; without severely affected donors +0.02 (p 0.949, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for CYP4A22 in dopamine neurons.

case closed: nothing better to follow up.